Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04694794 · ClinicalTrials.gov registry record · NA

Diminish Chemotherapy Related Side Effects Through Patient Education

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
36
Enrollment target

NCT04694794 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 36 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04694794, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target

Study Summary

Currently, there is a lack of patient education materials regarding cytotoxic chemotherapy side effects, research supported treatments, and the utilization of CAM by cancer patients at Penn State Cancer Institute. The investigators aim to develop an educational brochure, which educates patients about the chemotherapy side effects they may experience, and provide them with the tools to address the problem themselves, know when to contact their medical oncologist, and understand when it is appropriate to go to the Emergency Department. By educating patients regarding these problems, patient anxiety may decrease, the number of calls into the oncologist office may decrease, and Emergency Department visits may decrease, which would decrease costs for the patient, the hospital, and the health system. If this intervention is found to be useful and impactful, it can be further utilized within the Cancer Institute by other disease teams, by other Penn State institutions, or by other institutions across the country.

Interventions

  • OTHER Educational Brochure

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-03-24
Est. Completion 2023-08-21
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04694794

The ClinicalTrials.gov registry entry for NCT04694794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Educational Brochure is the first listed.

NCT04694794 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04694794 about?

NCT04694794 is a clinical study titled "Diminish Chemotherapy Related Side Effects Through Patient Education". Currently, there is a lack of patient education materials regarding cytotoxic chemotherapy side effects, research supported treatments, and the utilization of CAM by cancer patients at Penn State Cancer Institute. The investigators aim to develop an educational brochure, which educates patients abou...

What is the current status of trial NCT04694794?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-03-24. Estimated completion is 2023-08-21.

What interventions are being tested in trial NCT04694794?

The interventions under investigation include: Educational Brochure (OTHER).

Who is sponsoring clinical trial NCT04694794?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.